Literature DB >> 29917204

Sestrin2 aggravates oxidative stress of neurons by decreasing the expression of Nrf2.

L-L Zhang1, Z-J Zhang.   

Abstract

OBJECTIVE: Oxidative injury is an essential part of the pathological changes of cerebral ischemia-reperfusion. Sestrin2 (Sesn2), a conserved antioxidant protein, is activated under stress to protect cells against oxidative stress. This study mainly explored the function and mechanism of Sesn2 during cerebral ischemia-reperfusion injury in rats.
MATERIALS AND METHODS: Oxygen-glucose deprivation/reoxygenation (OGD/R) model of primary neurons was established. MTS and LDH (lactate dehydrogenase) kit were used to detect cell viability and cell damage by colorimetric method. The superoxide dismutase (SOD) kit and malondialdehyde (MDA) kit were used to access the level of SOD and MDA in neurons. To establish a model of middle cerebral artery occlusion (MCAO) in adult male Sprague-Dawley (SD) rats, the process of cerebral ischemia-reperfusion injury in animals was simulated. Western blot and immunofluorescence were utilized to further examine the relationship between the expression of Sesn2 and Nrf2 (nuclear factor E2 related factor 2).
RESULTS: Sesn2 aggravated neuronal damage and enhanced cell viability in OGD/R model. Intraventricular injection of Sesn2 siRNA lentivirus aggravated nerve function damage in MCAO model, increased cerebral infarction area and water content. Sesn2 overexpression resulted in the increase of total, nuclear levels of Nrf2, as well as the downstream proteins of Nrf2, sulfiredoxin1 (Srx1) and thioredoxin1 (Trx1). On the contrary, after knockdown of Sesn2, we obtained the opposite result. Knockdown of Sesn2 reduced Nrf2, Srx1 and Trx1 levels in rat cerebral cortex in MCAO model.
CONCLUSIONS: Sesn2 promoted the transfer of nuclear Nrf2 to the cytoplasm, it decreased the expressions of Nrf2 and its downstream proteins, Srx1 and Trx1. Meanwhile, it increased the cerebral ischemia-reperfusion injury by changing the distribution of Nrf2.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29917204     DOI: 10.26355/eurrev_201806_15176

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  7 in total

1.  The association between serum Sestrin2 and the risk of coronary heart disease in patients with type 2 diabetes mellitus.

Authors:  Xue Tian; Yu Gao; Min Zhong; Mowei Kong; Lihua Zhao; Zengbin Feng; Qitian Sun; Jianqiu He; Xiaoyan Liu
Journal:  BMC Cardiovasc Disord       Date:  2022-06-21       Impact factor: 2.174

Review 2.  Sestrin2 as a gatekeeper of cellular homeostasis: Physiological effects for the regulation of hypoxia-related diseases.

Authors:  Cunyao Pan; Zhaoli Chen; Chao Li; Tie Han; Hui Liu; Xinxing Wang
Journal:  J Cell Mol Med       Date:  2021-05-04       Impact factor: 5.310

3.  Investigation of Urinary Sestrin2 in Patients with Obstructive Sleep Apnea.

Authors:  Lu Bai; Chunying Sun; Huifen Zhai; Chen Chen; Xiaotian Hu; Xiulin Ye; Min Li; Yan Fang; Weimin Yang; Haoyan Wang; Shibo Sun
Journal:  Lung       Date:  2019-02-15       Impact factor: 2.584

4.  Protection of melatonin against acidosis-induced neuronal injuries.

Authors:  Yan Shi; Er-Li Cai; Can Yang; Chao-Yuan Ye; Peng Zeng; Xiao-Ming Wang; Ying-Yan Fang; Zhi-Kang Cheng; Qun Wang; Fu-Yuan Cao; Xin-Wen Zhou; Qing Tian
Journal:  J Cell Mol Med       Date:  2020-05-04       Impact factor: 5.310

Review 5.  SESTRINs: Emerging Dynamic Stress-Sensors in Metabolic and Environmental Health.

Authors:  Seung-Hyun Ro; Julianne Fay; Cesar I Cyuzuzo; Yura Jang; Naeun Lee; Hyun-Seob Song; Edward N Harris
Journal:  Front Cell Dev Biol       Date:  2020-12-03

6.  Dexmedetomidine Alleviates Lung Oxidative Stress Injury Induced by Ischemia-Reperfusion in Diabetic Rats via the Nrf2-Sulfiredoxin1 Pathway.

Authors:  Xuan Wang; Bing Zhang; Guangqi Li; Han Zhao; Xiaojun Tian; Junmin Yu; Yanwei Yin; Chao Meng
Journal:  Biomed Res Int       Date:  2022-02-24       Impact factor: 3.411

Review 7.  Sestrin2 in hypoxia and hypoxia-related diseases.

Authors:  Xiaojing Che; Jiagui Chai; Yan Fang; Xifeng Zhang; Anju Zu; Lin Li; Shibo Sun; Weimin Yang
Journal:  Redox Rep       Date:  2021-12       Impact factor: 4.412

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.